Hypertension, Vol 10, 254-258, Copyright © 1987 by American Heart Association
LM Resnick, JP Nicholson and JH Laragh
Ionic, hormonal, and blood pressure responses to a single oral dose of the
calcium channel blocker nifedipine were assessed in 25 essential
hypertensive subjects. When grouped according to their renin-sodium
profile, low renin subjects had a greater hypotensive response to
nifedipine (change in diastolic blood pressure -20.0 +/- 1.4 vs -6.4 +/-
1.0%; p less than 0.005) than did high renin hypertensive subjects. The
initial level of serum ionized calcium predicted the blood pressure
response to nifedipine (r = 0.70, p less than 0.001), as did the initial
plasma renin activity (r = 0.65, p less than 0.005). Nifedipine induced a
transient rise in serum ionized calcium (from 2.22 +/- 0.02 to 2.28 +/-
0.02 mEq/L; p less than 0.01), while plasma renin activity was consistently
elevated compared with initial values at 30 (p less than 0.01), 60 (p less
than 0.01), and 120 (p less than 0.05) minutes after drug administration.
By comparison, plasma aldosterone levels did not rise and even declined at
30 (p less than 0.01), 60 (p less than 0.05), and 120 (p less than 0.05)
minutes after nifedipine. These results suggest that low renin hypertension
is more critically dependent on extracellular calcium than are higher renin
forms and demonstrate that levels of serum ionized calcium, plasma renin
activity, or both may predict the sensitivity of blood pressure to calcium
channel blockade. Lastly, calcium may play a pivotal role in vivo in
coupling renin stimulation to adrenal aldosterone responses.
ARTICLES
Calcium, the renin-aldosterone system, and the hypotensive response to nifedipine
This article has been cited by other articles:
![]() |
K. Allikmets, T. Parik, R. Teesalu, and K. Allikmets Antihypertensive and Renal Effects of Isradipine in Essential Hypertension: Focus on Renin System Activity Angiology, November 1, 1997; 48(11): 977 - 983. [Abstract] [PDF] |
||||
![]() |
J. P. Nicholson, L. M. Resnick, and J. H. Laragh Hydrochlorothiazide Is Not Additive to Verapamil in Treating Essential Hypertension Arch Intern Med, January 1, 1989; 149(1): 125 - 128. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |